A series of novel imaging agents could light up tumors as they begin to form — before they turn deadly — and signal their transition to aggressive cancers. The compounds could have broad applications for detecting tumors earlier, monitoring a tumor’s transition from pre-malignancy to more aggressive growth, and defining tumor margins during surgical removal.